Technocrats Plasma Systems files FY26 investor presentation with BSE
- Technocrats Plasma Systems filed its FY26 investor presentation with the BSE on August 29, 2026
- The filing complies with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015
- Managing Director Arun Kumar signed the submission for the company
- The firm was formerly known as Technocrats Plasma Systems Private Limited
*this image is generated using AI for illustrative purposes only.
Technocrats Plasma Systems Limited has submitted its investor presentation for the financial year 2026 to the Bombay Stock Exchange. The filing was lodged on August 29, 2026, in compliance with regulatory disclosure norms.
The company, formerly known as Technocrats Plasma Systems Private Limited, filed the document under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015. Arun Kumar, Managing Director of Technocrats Plasma Systems , signed the submission.
Filing Details
The investor presentation covers the fiscal year ending March 2026. The filing serves as an informational record for investors and regulators. No specific financial metrics or operational updates were detailed in the cover letter accompanying the presentation.
| Detail | Information |
|---|---|
| Company | Technocrats Plasma Systems Limited |
| Filing Date | August 29, 2026 |
| Regulation | SEBI LODR Regulation 30 |
| Signatory | Arun Kumar (MD) |
The company is registered in Vasai East, Maharashtra. The submission includes the standard corporate identification numbers and contact details required for exchange records.
Historical Stock Returns for Technocrats Plasma Systems
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +93.07% | 0.0% | 0.0% | 0.0% | 0.0% |
What specific revenue growth targets or EBITDA margins are highlighted in the FY2026 investor presentation?
How does Technocrats Plasma Systems plan to leverage its plasma technology to capture market share in emerging sectors like semiconductor manufacturing or medical devices?
Are there any announced capital expenditure plans or new facility expansions detailed in the filing that could impact future cash flows?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
